18 0 2 0 2 B-lower_bound
- 2 3 2 3 O
65 3 5 3 5 B-upper_bound
years 6 11 6 11 I-upper_bound
old 12 15 12 15 O

Any 0 3 16 19 O
medications 4 15 20 31 B-treatment
taken 16 21 32 37 O
by 22 24 38 40 O
a 25 26 41 42 O
subject 27 34 43 50 O
at 35 37 51 53 O
the 38 41 54 57 O
enrollment 42 52 58 68 O
will 53 57 69 73 O
be 58 60 74 76 O
reviewed 61 69 77 85 O
regarding 70 79 86 95 O
their 80 85 96 101 O
compatibility 86 99 102 115 O
with 100 104 116 120 O
guanfacine 105 115 121 131 B-treatment
as 116 118 132 134 O
well 119 123 135 139 O
as 124 126 140 142 O
possible 127 135 143 151 O
confounding 136 147 152 163 O
side 148 152 164 168 O
effects 153 160 169 176 O
. 160 161 176 177 O
Subjects 162 170 178 186 O
will 171 175 187 191 O
be 176 178 192 194 O
allowed 179 186 195 202 O
to 187 189 203 205 O
take 190 194 206 210 O
non 195 198 211 214 B-treatment
- 198 199 214 215 I-treatment
opioid 199 205 215 221 I-treatment
pain 206 210 222 226 I-treatment
medications 211 222 227 238 I-treatment
except 223 229 239 245 O
for 230 233 246 249 O
gabapentinoids 234 248 250 264 B-treatment
and 249 252 265 268 O
amitriptyline 253 266 269 282 B-treatment
/ 266 267 282 283 O
nortriptyline 267 280 283 296 B-treatment
as 281 283 297 299 O
far 284 287 300 303 O
as 288 290 304 306 O
such 291 295 307 311 O
medications 296 307 312 323 O
do 308 310 324 326 O
not 311 314 327 330 O
have 315 319 331 335 O
incompatibility 320 335 336 351 O
with 336 340 352 356 O
guanfacine 341 351 357 367 O

Bradycardia 0 11 368 379 B-chronic_disease
( 12 13 380 381 O
resting 13 20 381 388 B-clinical_variable
heart 21 26 389 394 I-clinical_variable
rate 27 31 395 399 I-clinical_variable
< 32 33 400 401 O
60 34 36 402 404 B-upper_bound
bpm 37 40 405 408 I-upper_bound
) 40 41 408 409 O
will 42 46 410 414 O
be 47 49 415 417 O
reviewed 50 58 418 426 O
by 59 61 427 429 O
a 62 63 430 431 O
study 64 69 432 437 O
physician 70 79 438 447 O

Changes 0 7 448 455 O
to 8 10 456 458 O
current 11 18 459 466 O
or 19 21 467 469 O
adding 22 28 470 476 O
new 29 32 477 480 O
pain 33 37 481 485 O
treatment 38 47 486 495 B-treatment
while 48 53 496 501 O
enrolled 54 62 502 510 O
in 63 65 511 513 O
the 66 69 514 517 O
study 70 75 518 523 O
( 76 77 524 525 O
i.e. 77 81 525 529 O
opiates 82 89 530 537 B-treatment
, 89 90 537 538 O
epidural 91 99 539 547 B-treatment
steroid 100 107 548 555 I-treatment
injection 108 117 556 565 I-treatment
) 117 118 565 566 O
will 119 123 567 571 O
be 124 126 572 574 O
reviewed 127 135 575 583 O
by 136 138 584 586 O
the 139 142 587 590 O
study 143 148 591 596 O
physician 149 158 597 606 O

Chronic 0 7 607 614 O
neck 8 12 615 619 O
or 13 15 620 622 O
back 16 20 623 627 O
pain 21 25 628 632 O
condition 26 35 633 642 O
for 36 39 643 646 O
at 40 42 647 649 O
least 43 48 650 655 O
6 49 50 656 657 B-lower_bound
months 51 57 658 664 I-lower_bound

Currently 0 9 665 674 O
in 10 12 675 677 O
a 13 14 678 679 O
treatment 15 24 680 689 B-treatment
program 25 32 690 697 I-treatment
for 33 36 698 701 O
alcohol 37 44 702 709 O
or 45 47 710 712 O
drug 48 52 713 717 O
abuse 53 58 718 723 O
, 58 59 723 724 O
or 60 62 725 727 O
currently 63 72 728 737 O
on 73 75 738 740 O
methadone 76 85 741 750 B-treatment
or 86 88 751 753 O
buprenorphine 89 102 754 767 B-treatment
( 103 104 768 769 O
i.e. 104 108 769 773 O
suboxone 109 117 774 782 B-treatment
, 117 118 782 783 O
subutex 119 126 784 791 B-treatment
) 126 127 791 792 O
for 128 131 793 796 O
treatment 132 141 797 806 O
of 142 144 807 809 O
addiction 145 154 810 819 O
, 154 155 819 820 O
or 156 158 821 823 O
currently 159 168 824 833 O
prescribed 169 179 834 844 B-treatment
stimulants 180 190 845 855 I-treatment
for 191 194 856 859 O
treatment 195 204 860 869 O
of 205 207 870 872 O
ADHD 208 212 873 877 B-chronic_disease

Diagnosed 0 9 878 887 O
with 10 14 888 892 O
Raynaud 15 22 893 900 B-chronic_disease
's 22 24 900 902 I-chronic_disease
syndrome 25 33 903 911 I-chronic_disease

Has 0 3 912 915 O
known 4 9 916 921 O
pre 10 13 922 925 O
- 13 14 925 926 O
existing 14 22 926 934 O
severe 23 29 935 941 O
cardiovascular 30 44 942 956 B-chronic_disease
disease 45 52 957 964 I-chronic_disease
( 53 54 965 966 O
i.e. 54 58 966 970 O
arrhythmia 59 69 971 981 B-chronic_disease
- 70 71 982 983 O
prolonged 72 81 984 993 O
QT 82 84 994 996 B-clinical_variable
interval 85 93 997 1005 I-clinical_variable
> 94 95 1006 1007 O
440ms 96 101 1008 1013 B-lower_bound
) 101 102 1013 1014 O
, 102 103 1014 1015 O
cerebrovascular 104 119 1016 1031 B-chronic_disease
disease 120 127 1032 1039 I-chronic_disease
/ 127 128 1039 1040 O
accident 128 136 1040 1048 O
( 137 138 1049 1050 O
i.e. 138 142 1050 1054 O
, 142 143 1054 1055 O
stroke 144 150 1056 1062 B-chronic_disease
) 150 151 1062 1063 O
, 151 152 1063 1064 O
hepatic 153 160 1065 1072 B-chronic_disease
or 161 163 1073 1075 I-chronic_disease
renal 164 169 1076 1081 I-chronic_disease
impairment 170 180 1082 1092 I-chronic_disease
, 180 181 1092 1093 O
CNS 182 185 1094 1097 B-chronic_disease
condition 186 195 1098 1107 I-chronic_disease
, 195 196 1107 1108 O
metabolic 197 206 1109 1118 B-chronic_disease
condition 207 216 1119 1128 I-chronic_disease
, 216 217 1128 1129 O
or 218 220 1130 1132 O
history 221 228 1133 1140 O
of 229 231 1141 1143 O
syncope 232 239 1144 1151 B-chronic_disease

Has 0 3 1152 1155 O
other 4 9 1156 1161 O
chronic 10 17 1162 1169 O
pain 18 22 1170 1174 O
conditions 23 33 1175 1185 O
such 34 38 1186 1190 O
as 39 41 1191 1193 O
fibromyalgia 42 54 1194 1206 B-chronic_disease
or 55 57 1207 1209 O
joint 58 63 1210 1215 O
osteoarthritis 64 78 1216 1230 B-chronic_disease
that 79 83 1231 1235 O
are 84 87 1236 1239 O
predominant 88 99 1240 1251 O
over 100 104 1252 1256 O
back 105 109 1257 1261 O
and 110 113 1262 1265 O
neck 114 118 1266 1270 O
pain 119 123 1271 1275 O
with 124 128 1276 1280 O
regard 129 135 1281 1287 O
to 136 138 1288 1290 O
its 139 142 1291 1294 O
intensity 143 152 1295 1304 O
( 153 154 1305 1306 O
VAS 154 157 1306 1309 O
) 157 158 1309 1310 O

Has 0 3 1311 1314 O
taken 4 9 1315 1320 O
Methadone 10 19 1321 1330 B-treatment
, 19 20 1330 1331 O
Suboxone 21 29 1332 1340 B-treatment
, 29 30 1340 1341 O
Fentanyl 31 39 1342 1350 B-treatment
, 39 40 1350 1351 O
and/or 41 47 1352 1358 O
Tramadol 48 56 1359 1367 B-treatment
in 57 59 1368 1370 O
the 60 63 1371 1374 O
last 64 68 1375 1379 B-upper_bound
six 69 72 1380 1383 I-upper_bound
( 73 74 1384 1385 I-upper_bound
6 74 75 1385 1386 I-upper_bound
) 75 76 1386 1387 I-upper_bound
months 77 83 1388 1394 I-upper_bound

Has 0 3 1395 1398 O
taken 4 9 1399 1404 O
guanfacine 10 20 1405 1415 B-treatment
( 21 22 1416 1417 O
or 22 24 1417 1419 O
other 25 30 1420 1425 O
alpha-2AR 31 40 1426 1435 B-treatment
agonists 41 49 1436 1444 I-treatment
) 49 50 1444 1445 O
in 51 53 1446 1448 O
the 54 57 1449 1452 O
last 58 62 1453 1457 B-upper_bound
six 63 66 1458 1461 I-upper_bound
( 67 68 1462 1463 I-upper_bound
6 68 69 1463 1464 I-upper_bound
) 69 70 1464 1465 I-upper_bound
months 71 77 1466 1472 I-upper_bound

Hypotension 0 11 1473 1484 B-chronic_disease
( 12 13 1485 1486 O
SBP 13 16 1486 1489 B-clinical_variable
< 17 18 1490 1491 O
90 19 21 1492 1494 B-upper_bound
mmHg 22 26 1495 1499 I-upper_bound
and 27 30 1500 1503 O
DBP 31 34 1504 1507 B-clinical_variable
< 35 36 1508 1509 O
60 37 39 1510 1512 B-upper_bound
mmHg 40 44 1513 1517 I-upper_bound
for 45 48 1518 1521 O
female 49 55 1522 1528 B-gender
or 56 58 1529 1531 O
SBP 59 62 1532 1535 O
< 63 64 1536 1537 O
100 65 68 1538 1541 B-upper_bound
mmHg 69 73 1542 1546 I-upper_bound
and 74 77 1547 1550 O
DBP 78 81 1551 1554 O
< 82 83 1555 1556 O
60 84 86 1557 1559 O
mmHg 87 91 1560 1564 O
for 92 95 1565 1568 O
male 96 100 1569 1573 O
; 100 101 1573 1574 O
measured 102 110 1575 1583 O
while 111 116 1584 1589 O
in 117 119 1590 1592 O
a 120 121 1593 1594 O
sitting 122 129 1595 1602 O
position 130 138 1603 1611 O
) 138 139 1611 1612 O
will 140 144 1613 1617 O
be 145 147 1618 1620 O
reviewed 148 156 1621 1629 O
by 157 159 1630 1632 O
a 160 161 1633 1634 O
study 162 167 1635 1640 O
physician 168 177 1641 1650 O

Intolerable 0 11 1651 1662 O
allergies 12 21 1663 1672 O
or 22 24 1673 1675 O
has 25 28 1676 1679 O
had 29 32 1680 1683 O
a 33 34 1684 1685 O
severe 35 41 1686 1692 O
adverse 42 49 1693 1700 O
reaction 50 58 1701 1709 O
to 59 61 1710 1712 O
study 62 67 1713 1718 O
medication 68 78 1719 1729 B-treatment
( 79 80 1730 1731 O
i.e. 80 84 1731 1735 O
guanfacine 85 95 1736 1746 B-treatment
, 95 96 1746 1747 O
lactose 97 104 1748 1755 O
, 104 105 1755 1756 O
vitamin 106 113 1757 1764 B-treatment
B2 114 116 1765 1767 I-treatment
a.k.a 117 122 1768 1773 O
. 122 123 1773 1774 O
riboflavin 124 134 1775 1785 B-treatment
) 134 135 1785 1786 O

Major 0 5 1787 1792 O
psychiatric 6 17 1793 1804 B-chronic_disease
disorders 18 27 1805 1814 I-chronic_disease
that 28 32 1815 1819 O
required 33 41 1820 1828 O
hospitalization 42 57 1829 1844 O
in 58 60 1845 1847 O
the 61 64 1848 1851 O
past 65 69 1852 1856 B-upper_bound
6 70 71 1857 1858 I-upper_bound
months 72 78 1859 1865 I-upper_bound
such 79 83 1866 1870 O
as 84 86 1871 1873 O
: 86 87 1873 1874 O
major 88 93 1875 1880 B-chronic_disease
depression 94 104 1881 1891 I-chronic_disease
, 104 105 1891 1892 O
bipolar 106 113 1893 1900 B-chronic_disease
disorder 114 122 1901 1909 I-chronic_disease
, 122 123 1909 1910 O
schizophrenia 124 137 1911 1924 B-chronic_disease
, 137 138 1924 1925 O
anxiety 139 146 1926 1933 B-chronic_disease
disorder 147 155 1934 1942 I-chronic_disease
, 155 156 1942 1943 O
or 157 159 1944 1946 O
psychotic 160 169 1947 1956 B-chronic_disease
disorders 170 179 1957 1966 I-chronic_disease

On 0 2 1967 1969 O
a 3 4 1970 1971 O
stable 5 11 1972 1978 O
morphine 12 20 1979 1987 B-treatment
equivalent 21 31 1988 1998 O
dose 32 36 1999 2003 O
of 37 39 2004 2006 O
at 40 42 2007 2009 O
least 43 48 2010 2015 O
60mg 49 53 2016 2020 B-lower_bound
/ 53 54 2020 2021 I-lower_bound
day 54 57 2021 2024 I-lower_bound
and 58 61 2025 2028 O
â‰¤ 62 63 2029 2030 O
240mg 64 69 2031 2036 B-upper_bound
/ 69 70 2036 2037 I-upper_bound
day 70 73 2037 2040 I-upper_bound
for 74 77 2041 2044 O
at 78 80 2045 2047 O
least 81 86 2048 2053 O
3 87 88 2054 2055 B-lower_bound
months 89 95 2056 2062 I-lower_bound

Pregnant 0 8 2063 2071 B-pregnancy
or 9 11 2072 2074 O
breastfeeding 12 25 2075 2088 O

Sensory 0 7 2089 2096 O
deficits 8 16 2097 2105 O
at 17 19 2106 2108 O
site 20 24 2109 2113 O
of 25 27 2114 2116 O
QST 28 31 2117 2120 O
, 31 32 2120 2121 O
such 33 37 2122 2126 O
as 38 40 2127 2129 O
peripheral 41 51 2130 2140 B-chronic_disease
neuropathy 52 62 2141 2151 I-chronic_disease

Subjects 0 8 2152 2160 O
are 9 12 2161 2164 O
on 13 15 2165 2167 O
antihypertensive 16 32 2168 2184 B-treatment
drugs 33 38 2185 2190 I-treatment
( 39 40 2191 2192 O
e.g. 40 44 2192 2196 O
, 44 45 2196 2197 O
a 46 47 2198 2199 O
beta 48 52 2200 2204 B-treatment
- 52 53 2204 2205 I-treatment
blocker 53 60 2205 2212 I-treatment
) 60 61 2212 2213 O
that 62 66 2214 2218 O
result 67 73 2219 2225 O
in 74 76 2226 2228 O
hypotension 77 88 2229 2240 B-chronic_disease
and/or 89 95 2241 2247 O
bradycardia 96 107 2248 2259 B-treatment
as 108 110 2260 2262 O
defined 111 118 2263 2270 O
above 119 124 2271 2276 O

Subjects 0 8 2277 2285 O
are 9 12 2286 2289 O
on 13 15 2290 2292 O
medications 16 27 2293 2304 B-treatment
that 28 32 2305 2309 O
are 33 36 2310 2313 O
ligands 37 44 2314 2321 O
for 45 48 2322 2325 O
alpha2 49 55 2326 2332 B-treatment
- 55 56 2332 2333 I-treatment
adrenergic 56 66 2333 2343 I-treatment
receptors 67 76 2344 2353 I-treatment
including 77 86 2354 2363 O
antipsychotic 87 100 2364 2377 B-treatment
drugs 101 106 2378 2383 I-treatment
( 107 108 2384 2385 O
e.g. 108 112 2385 2389 O
clozapine 113 122 2390 2399 B-treatment
) 122 123 2399 2400 O
and 124 127 2401 2404 O
tricyclic 128 137 2405 2414 B-treatment
or 138 140 2415 2417 O
tetracyclic 141 152 2418 2429 B-treatment
antidepressants 153 168 2430 2445 I-treatment
( 169 170 2446 2447 O
e.g. 170 174 2447 2451 O
imipramine 175 185 2452 2462 B-treatment
, 185 186 2462 2463 O
mirtazapine 187 198 2464 2475 B-treatment
, 198 199 2475 2476 O
mianserin 200 209 2477 2486 B-treatment
) 209 210 2486 2487 O

Subjects 0 8 2488 2496 O
are 9 12 2497 2500 O
on 13 15 2501 2503 O
medications 16 27 2504 2515 B-treatment
that 28 32 2516 2520 O
serve 33 38 2521 2526 O
as 39 41 2527 2529 O
CYP3A4/5 42 50 2530 2538 B-treatment
inhibitors 51 61 2539 2549 I-treatment
or 62 64 2550 2552 O
CYP3A4 65 71 2553 2559 B-treatment
inducers 72 80 2560 2568 I-treatment
including 81 90 2569 2578 O
, 90 91 2578 2579 O
but 92 95 2580 2583 O
are 96 99 2584 2587 O
not 100 103 2588 2591 O
limited 104 111 2592 2599 O
to 112 114 2600 2602 O
, 114 115 2602 2603 O
valproic 116 124 2604 2612 B-treatment
acid 125 129 2613 2617 I-treatment
, 129 130 2617 2618 O
macrolide 131 140 2619 2628 B-treatment
antibiotics 141 152 2629 2640 I-treatment
, 152 153 2640 2641 O
antifungal 154 164 2642 2652 B-treatment
drugs 165 170 2653 2658 I-treatment
, 170 171 2658 2659 O
St. 172 175 2660 2663 B-treatment
John 176 180 2664 2668 I-treatment
wort 181 185 2669 2673 I-treatment
, 185 186 2673 2674 O
ACE 187 190 2675 2678 B-treatment
inhibitors 191 201 2679 2689 I-treatment
, 201 202 2689 2690 O
nefazodone 203 213 2691 2701 B-treatment
( 214 215 2702 2703 I-treatment
antidepressant 215 229 2703 2717 I-treatment
) 229 230 2717 2718 I-treatment
, 230 231 2718 2719 O
calcium 232 239 2720 2727 B-treatment
channel 240 247 2728 2735 I-treatment
blockers 248 256 2736 2744 I-treatment
, 256 257 2744 2745 O
H2 258 260 2746 2748 B-treatment
- 260 261 2748 2749 I-treatment
receptor 261 269 2749 2757 I-treatment
antagonists 270 281 2758 2769 I-treatment
, 281 282 2769 2770 O
anti 283 287 2771 2775 B-treatment
- 287 288 2775 2776 I-treatment
HIV 288 291 2776 2779 I-treatment
or 292 294 2780 2782 I-treatment
AIDS 295 299 2783 2787 I-treatment
drugs 300 305 2788 2793 I-treatment
, 305 306 2793 2794 O
and 307 310 2795 2798 O
antiepileptic 311 324 2799 2812 B-treatment
drugs 325 330 2813 2818 I-treatment

Takes 0 5 2819 2824 O
vitamin 6 13 2825 2832 B-treatment
B2 14 16 2833 2835 I-treatment
> 17 18 2836 2837 O
1.6mg 19 24 2838 2843 B-lower_bound
/ 24 25 2843 2844 O
day 25 28 2844 2847 O
during 29 35 2848 2854 O
the 36 39 2855 2858 O
study 40 45 2859 2864 O

VAS 0 3 2865 2868 B-clinical_variable
score 4 9 2869 2874 I-clinical_variable
of 10 12 2875 2877 O
4 13 14 2878 2879 B-lower_bound
- 14 15 2879 2880 O
8 15 16 2880 2881 B-upper_bound
, 16 17 2881 2882 O
despite 18 25 2883 2890 O
opioid 26 32 2891 2897 B-treatment
therapy 33 40 2898 2905 I-treatment

